In vivo imaging of brain nicotinic acetylcholine receptors with 5- [123I]iodo-A-85380 using single photon emission computed tomography

Life Sciences

Volumn 63, Issue 25, 1998, Pages

  Chefer, Svetlana I ^a   Horti, Andrew G ^a   Lee, Kan Sam ^b   Koren, Andrei O ^a   Jones, Douglas W ^b   Gorey, Julia G ^b   Links, Jonathan M ^a   Mukhin, Alexey G ^a   Weinberger, Daniel R ^b   London, Edythe D ^a,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

5 123I iodo 3 (2(S) azetidinylmethoxy)pyridine (5 123I iodo A 85380); Nicotinic acetylcholine receptor; Rhesus monkey; Single photon emission computed tomography

Indexed keywords

2 FLUORO 3 (AZETIDINYLMETHOXY)PYRIDINE F 18; 5 IODO 3 (AZETIDINYLMETHOXY)PYRIDINE I 123; CYTISINE; NICOTINIC RECEPTOR; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BASAL GANGLION; CEREBELLUM; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FRONTAL CORTEX; IN VIVO STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; RADIOACTIVITY; RECEPTOR AFFINITY; RHESUS MONKEY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBCUTANEOUS DRUG ADMINISTRATION; THALAMUS;

ANIMALIA; MACACA MULATTA;

EID: 0032515198     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00514-1     Document Type: Article

References (20)

1. 1. M.W. DECKER, J.D. BRIONI, A.W. BANNON and S.P. ARNERIC, Life Sci. 56 545-570 (1995).
2. 2. E.D. LONDON, M.J. BALL and S.B. WALLER, Neurochem. Res. 14 745-750 (1989).
3. 3. P.J. WHITEHOUSE, A.M MARTINO, P.G. ANTUONO, P.R. LOWENSTEIN, J.T COYLE, D.L PRICE and K.J. KELLAR, Brain Res. 371 146-151 (1986).
4. 4. J.E. HENNINGFIELD and P.P. WOODSON, J. Subst. Abuse. I 301-317 (1989).
5. 5. J.-P. CHANGEUX, A. DEVILLERS-THIERY and P. CHEMOUILLI, Science 225 1335-1345 (1984).
6. 6. M. MAZIERE, G. BERGER, R. MASSE, D. PHIMMER and D. COMAR, Electrophysiological Effects of Nicotine, A. Remond and C Izard (Eds.), 31-47, Elsevier, Amsterdam (1979).
7. 7. E.P. BROUSSOLLE, D.F. WONG, R.J. FANELLI and E.D. LONDON, Life Sci. 44 1123-1132 (1989).
8. 8. T.F. SPANDE, H.M. GARRAFFO, M.W. EDWARDS, H. YEH, L. PANELL and J.W. DALY, J. Am. Chem. Soc. 114 3475-3478 (1992).
9. 9. V.L. VILLEMAGNE, A. HORTI, U. SCHEFFEL, H.T. RAVERT, P. FINLEY D. CLOUGH, E.D. LONDON, H.N. WAGNER and R.F. DANNALS, J. Nucl. Med. 38 1737-1741 (1997).
10. 10. J.L. MUSACHIO, V.L. VILLEMAGNE, U. SCHEFFEL, M. STATHIS, P. FINLEY, A. HORTI, E.D. LONDON and R.F. DANNALS, Synapse 26 392-399 (1997).
11. 11. P.E. MOLINA, Y.-S. DING, F.I. CARROL, F. LIANG, N. VOLKOW, M. KUHAR, N. PAPPAS, P. KING, N. ABUMRAD and J.S. FOWLER, J. Nucl. Med. 38 287P (1997).
12. 12. M.A. ABREO, N.-H. LIN, D.S. GARVEY, D.E. GUNN, A.-M. HETTINGER, J.T. WASICAK, P.A. PAVLIK, Y.C. MARTIN, D.L. DONNELLY-ROBERTS, D.J. ANDERSON, J.P. SULLIVAN, M. WILLIAMS, S.P. ARNERIC and M.W. HOLLADAY, J. Med. Chem. 39 817-825 (1996).
13. 13. J.P. SULLIVAN, D. DONNELLY-ROBERTS, C.A. BRIGGS, D.J. ANDERSON, M. GOPALAKRISHNAN, M. PIATTONI-KAPLAN, J.E. CAMPBELL, D.G. McKENNA, E. MOLINARI, A.-M. HETTINGER, D.S. GARVEY, J.T. WASICAK, M.W. HOLLADAY, M. WILLIAMS and S.P. ARNERIC, Neuropharmacology 35 725-734 (1996).
14. 14. A. HORTI, A.O. KOREN, H.T. RAVERT, J.L. MUSACHIO, W.B. MATHEWS, E.D. LONDON and R.F. DANNALS, J. Labelled Comp. Radiopharm. 41 309-318 (1998).
15. 15. B.D. VAUPEL, A.G. MUKHIN, A.S. KIMES, A.G. HORTI, A.O. KOREN and E.D. LONDON, Neuroreport 9 (1998).
16. 16. J.L. MUSACHIO, U. SCHEFFEL, P.A. FINLEY, Y. ZHAN, T. MOCHIZUKI, H.N. WAGNER and R.F. DANNALS, Life Sci. 62 351-357 (1998).
17. 17. A.G. HORTI, A.O. KOREN, U. SCHEFFEL, A.S. KIMES, H.T. RAVERT, J.L. MUSAHIO, P.A. FINLEY, Y. ZHAN, R.F. DANNALS and E.D. LONDON, Soc. Neurosci. Abst. 23 382 (1997)
18. 18. A. NORDBERG, I. ALAFUZOFF and B. WENBLAD, J. Neurosci. Res. 31 103-111 (1992).
19. 19. L.W. SWANSON, D.M. SMMONS, P.J. WHITING and J. LINDSTROM, J. Neurosci. 7 3334-3342 (1987).
20. 20. L. FARDE, L. ERIKSSON, G. BLOMQUIST and C. HALLDIN, J. Cereb. Blood Flow Metab. 9 696-708 (1989).